Results 151 to 160 of about 1,831,806 (317)
Recent Advances in Highly Luminescent Carbon Dots
Here, a comprehensive summary of the advancements is provided in highly luminescent carbon dots across various luminescence bands since their discovery in 2004. It systematically covers the synthesis, structural characteristics, preparation strategies, and essential purification of these carbon dots, along with their applications in efficient ...
Yupeng Liu+6 more
wiley +1 more source
INVOLVEMENT OF THE LYMPH-NODES IN CARCINOMA OP THE RECTUM
James Robert McVay
openalex +2 more sources
PHASE MICROSCOPY STUDIES OF HODGKIN’S DISEASE LYMPH NODES IN RELATION TO HISTOGENESIS OF THE STERNBERG-REED CELL [PDF]
G Hoffmann, Antonio Rottino
openalex +1 more source
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray+2 more
wiley +1 more source
THE SIGNIFICANCE OF ABERRANT OF HETEROTOPIC PAROTID GLAND TISSUE IN LYMPH NODES*
R Brown, Romy Gaillard, James A. Turner
openalex +2 more sources
Material design for lymph node drug delivery
A. Schudel, David M. Francis, S. Thomas
semanticscholar +1 more source
NeoCast is a next‐generation, solvent‐free, non‐adhesive liquid embolic designed for indications where deep occlusion is desired (e.g., tumors and chronic subdural hematoma). This novel agent offers ideal embolic properties: injectability, controllability, excellent visibility, and biocompatibility.
Quynh P. Pham+16 more
wiley +1 more source
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq+4 more
wiley +1 more source